PBH vs. IPAR, HLF, NUS, USNA, NATR, MED, VERU, EL, BAX, and BIO
Should you be buying Prestige Consumer Healthcare stock or one of its competitors? The main competitors of Prestige Consumer Healthcare include Interparfums (IPAR), Herbalife (HLF), Nu Skin Enterprises (NUS), USANA Health Sciences (USNA), Nature's Sunshine Products (NATR), MEDIFAST (MED), Veru (VERU), Estee Lauder Companies (EL), Baxter International (BAX), and Bio-Rad Laboratories (BIO).
Prestige Consumer Healthcare vs. Its Competitors
Prestige Consumer Healthcare (NYSE:PBH) and Interparfums (NASDAQ:IPAR) are both mid-cap personal products companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, earnings, risk, valuation, analyst recommendations, profitability, institutional ownership and media sentiment.
Prestige Consumer Healthcare presently has a consensus price target of $96.80, indicating a potential upside of 53.71%. Interparfums has a consensus price target of $162.00, indicating a potential upside of 58.87%. Given Interparfums' stronger consensus rating and higher probable upside, analysts plainly believe Interparfums is more favorable than Prestige Consumer Healthcare.
Prestige Consumer Healthcare has a beta of 0.46, meaning that its share price is 54% less volatile than the S&P 500. Comparatively, Interparfums has a beta of 1.44, meaning that its share price is 44% more volatile than the S&P 500.
In the previous week, Prestige Consumer Healthcare had 15 more articles in the media than Interparfums. MarketBeat recorded 16 mentions for Prestige Consumer Healthcare and 1 mentions for Interparfums. Interparfums' average media sentiment score of 1.42 beat Prestige Consumer Healthcare's score of 0.53 indicating that Interparfums is being referred to more favorably in the news media.
Prestige Consumer Healthcare pays an annual dividend of $1.90 per share and has a dividend yield of 3.0%. Interparfums pays an annual dividend of $3.20 per share and has a dividend yield of 3.1%. Prestige Consumer Healthcare pays out 44.6% of its earnings in the form of a dividend. Interparfums pays out 64.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Interparfums has increased its dividend for 4 consecutive years. Interparfums is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
Prestige Consumer Healthcare has a net margin of 19.02% compared to Interparfums' net margin of 11.03%. Interparfums' return on equity of 16.45% beat Prestige Consumer Healthcare's return on equity.
99.9% of Prestige Consumer Healthcare shares are held by institutional investors. Comparatively, 55.6% of Interparfums shares are held by institutional investors. 1.4% of Prestige Consumer Healthcare shares are held by company insiders. Comparatively, 43.7% of Interparfums shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Prestige Consumer Healthcare has higher earnings, but lower revenue than Interparfums. Prestige Consumer Healthcare is trading at a lower price-to-earnings ratio than Interparfums, indicating that it is currently the more affordable of the two stocks.
Summary
Interparfums beats Prestige Consumer Healthcare on 13 of the 19 factors compared between the two stocks.
Get Prestige Consumer Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for PBH and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding PBH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Prestige Consumer Healthcare Competitors List
Related Companies and Tools
This page (NYSE:PBH) was last updated on 9/24/2025 by MarketBeat.com Staff